Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Metastatic Prostate Cancer
NCT04776889Phase 4Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in Metastatic Prostate Cancer (mPC), sponsored by National Cancer Institute. Started Jan 2019; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT04776889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776889.